Portopulmonary hypertension epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Portopulmonary hypertension}} {{CMG}} ==Overview== ==Epidemiology and Demographics== PPH presents roughly equally in male and female cirrhotics; 71% female in an..." |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Portopulmonary hypertension}} | {{Portopulmonary hypertension}} | ||
{{CMG}} | {{CMG}}; {{AE}} | ||
{{PleaseHelp}} | |||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
PPH presents roughly equally in male and female cirrhotics; 71% female in an American series and 57% male in a larger French series.<ref name=LePavec> Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008</ref><ref name=Kawut>Kawut SM et al. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48</ref> Typically, patients present in their fifth decade, aged 49 +/- 11 years on average.<ref name=LePavec> Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008</ref><ref> Bejaminov et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003; 52:1355-1362</ref> | PPH presents roughly equally in male and female cirrhotics; 71% female in an American series and 57% male in a larger French series.<ref name=LePavec> Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008</ref><ref name=Kawut>Kawut SM et al. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48</ref> Typically, patients present in their fifth decade, aged 49 +/- 11 years on average.<ref name=LePavec> Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008</ref><ref> Bejaminov et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003; 52:1355-1362</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 18:25, 18 July 2016
|
Portopulmonary hypertension Microchapters |
|
Differentiating Portopulmonary hypertension from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Portopulmonary hypertension epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Portopulmonary hypertension epidemiology and demographics |
|
FDA on Portopulmonary hypertension epidemiology and demographics |
|
CDC on Portopulmonary hypertension epidemiology and demographics |
|
Portopulmonary hypertension epidemiology and demographics in the news |
|
Blogs on Portopulmonary hypertension epidemiology and demographics |
|
Directions to Hospitals Treating Portopulmonary hypertension |
|
Risk calculators and risk factors for Portopulmonary hypertension epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Epidemiology and Demographics
PPH presents roughly equally in male and female cirrhotics; 71% female in an American series and 57% male in a larger French series.[1][2] Typically, patients present in their fifth decade, aged 49 +/- 11 years on average.[1][3]
References
- ↑ 1.0 1.1 Le Pavec et al. Portopulmonary Hypertension: Survival and Prognostic Factors. Am J Respir Crit Care Med Vol 178. pp 637–643, 2008
- ↑ Kawut SM et al. Clinical Risk Factors for Portopulmonary Hypertension. Hepatology 2008;48
- ↑ Bejaminov et al. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 2003; 52:1355-1362